Visiongain

Visiongain is a specialist, independent business information company. The company provides cutting edge products & services across the telecom, pharmaceutical/biotech & defence sectors. Their portfolio of products range from management reports, consultancy, e-zines to business conferences and industry awards.

Results 21 - 40 of 128 go to 1st page

first

previous 1 2 3 4 5 6 7 next

last

Title	Date	Price
Global Cardiovascular Drugs Market 2009-2024	Jun 2009	£1,499
World Respiratory Disorders Market 2009-2024	Jun 2009	£1,499
Mobile Geotagging - a new market opportunity from within the LBS and UGC markets Analysis and Forecasts 2009-2014	Jun 2009	£1,499
The Unmanned Aerial Vehicles (UAV) Market 2009-2019	May 2009	£1,499
Mobile Social Networking and User Generated Content Market Insight 2009-2014	May 2009	£1,499
The Global OTC Pharmaceutical Market 2009-2024	May 2009	£1,499
Monoclonal Antibodies in Cancer Therapy 2009-2024	May 2009	£1,499
In Vitro Diagnostics Market Analysis 2009-2024	May 2009	£1,499
The IMS Report Market Forecast 2009-2014	May 2009	£1,499
Pharmacovigilance Report and Analysis 2009 Present Challenges and Future Goals	Apr 2009	£1,499
The Military Airlift Market 2009-2019	Apr 2009	£1,499
The Mvoip Market 2009-2014 Successfully Profiting From Voip Over Mobile	Apr 2009	£1,499
Biosimilars and Follow-On Biologics Report The Global Outlook 2009-2024	Apr 2009	£1,499
Apple's iPhone & Mobile Report 2009 Competing successfully with Devices, Content & Services from Apple	Apr 2009	£1,499
Stem Cells - The Hype & Hope World Analysis 2009-2024	Mar 2009	£1,499
Google Android and Nokia Symbian Increasing content, service and advertising market opportunities from competition in mobile OS, 2009-2014	Mar 2009	£1,499
Rural Mobile Connectivity Prospects 2009-2014 Increasing Business Growthand Development from Rural Mobile Expansion	Mar 2009	£1,499
The Global Multiple Sclerosis Market 2009-2024	Mar 2009	£1,499
Mobile Music Report Analysis, Forecasts and Markets 2009	Mar 2009	£1,499
Anti-Obesity Treatments Analysis & Forecasts 2009-2024	Feb 2009	£1,499